CLINICAL_TRIALS
research
· 2013-07-19
Clinical Trial Update: A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807 [EARLY_Phase 1]
Summary
The trial update reports termination of a Phase 0, open-label exploratory safety study of [F-18]T807 (AV-1451/Flortaucipir) in Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimers Disease, AD | EARLY_Phase 1 | Status: TERMINATED